Hologic Stock News

Surgical Imaging Arms Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market Insights Reports

Related Stocks: GOOGL , BAC , PNC , KDP , ICE , MCD , HOLX , AJG , NVST ,

PALM BEACH, Fla. , Dec. 10, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Ongoing advancements in cancer research continue to lead to the introduction of newer and better treatment options including drug therapies. The provision of newer drugs and treatments is expected to improve the diagnostic and treatment rate for triple-negative breast cancer . Some of the recent clinical efforts are being targeted at the molecular level characterization of triple-negative breast cancer across emerging therapeutic targets such as epigenetic proteins, PARP1, androgen receptors, receptor and non-receptor tyrosine kinases, and immune checkpoints. These initiatives are anticipated to boost revenue growth of the triple-negative breast cancer treatment market. In a new research study, Persistence Market Research estimates the global triple-negative breast cancer treatment market revenue to cross US$ 720 Mn by 2026 from an estimated valuation of just under US$ 505 Mn in 2018. This is indicative of a CAGR of 4.7% during the period 2018 to 2026.

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #Biotheranostics--Hologic Presents Breast Cancer Index™ Data at SABCS 2021 Showing Net Benefit Predictive Value for Endocrine Therapy Continuation

Robeco Institutional Asset Management B.V. cut its position in Hologic, Inc. (NASDAQ:HOLX) by 16.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,690 shares of the medical equipment providers stock after selling 13,255 shares during the quarter. Robeco Institutional Asset Management B.V.s []

Los Angeles, United State: The global Digital Breast Tomosynthesis (DBT) Equipment market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures.

Los Angeles, United State: The global Bone Densitometer Devices market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section

Related Stocks: HCA , BIO.B , PFE , PKI , TDY , HOLX , IDXX , MNST , EPC , UVV , HSIC , TECH , PRMW , BTI ,

In the latest trading session, Hologic (HOLX) closed at $76.05, marking a -0.13% move from the previous day.

Chevy Chase Trust Holdings Inc. lowered its stake in Hologic, Inc. (NASDAQ:HOLX) by 4.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 192,414 shares of the medical equipment providers stock after selling 8,187 shares during the period. Chevy Chase []

Hologic pledged $5 million in donations to local charities serving areas where its facilities are located. The biotech company''s location in San Diego is its largest facility.

The rise in the prevalence of osteoporosis in the aged populace and women aged above 50 has led to a surge in requests for bone mineral densitometry. Rising cognizance about osteoporosis and pains by various fundamentals are increasing consciousness among

Assenagon Asset Management S.A. decreased its stake in Hologic, Inc. (NASDAQ:HOLX) by 33.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,136 shares of the medical equipment providers stock after selling 45,248 shares during the quarter. Assenagon Asset Management S.A.s holdings in Hologic were []

New Mexico Educational Retirement Board reduced its stake in Hologic, Inc. (NASDAQ:HOLX) by 2.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,750 shares of the medical equipment providers stock after selling 400 shares during the quarter. New Mexico Educational []

Hologic (HOLX) closed at $73.77 in the latest trading session, marking a +0.97% move from the prior day.